ProjectGENFI NeuroDev – GENETIC FRONTOTEMPORAL DEMENTIA INITIAVE FOR NEURODEVELOPMENT

Basic data

Acronym:
GENFI NeuroDev
Title:
GENETIC FRONTOTEMPORAL DEMENTIA INITIAVE FOR NEURODEVELOPMENT
Duration:
28/03/2024 to 31/03/2027
Abstract / short description:
This is an international multi-centre cohort study of first and second degree family members of individuals who carry FTD mutations in MAPT, GRN or C9ORF72 repeat expansions for youths between the ages 9-17.

Primary objectives:

To determine whether youths between the ages of 9 and 17 who carry FTD mutations in MAPT, GRN, or C9orf72 repeat expansions show differences compared to age matched non-carriers at baseline and over two year interval follow ups:

1) Brain development as measured by structural and functional MRI
2) Functional outcomes indexed by developmental history, behavioural and cognitive assessments

Exploratory outcome measure:
1) Fluid biomarkers of synaptic markers, axonal markers, and neuroinflammation markers
Keywords:
neurodegenerative disorder
neurodegenerative Erkrankung
neurology
Neurologie
dementia
Demenz

Involved staff

Managers

Faculty of Medicine
University of Tübingen
University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine

Other staff

University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine

Local organizational units

Department of Neurology with Focus on Neurodegenerative Disorders
University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine

Funders

London, Ontario, Canada

Cooperations

London, Ontario, Canada
Help

will be deleted permanently. This cannot be undone.